Abstract
Oncolytic immunotherapy reduces the size of melanoma tumors in phase 3 trial
EV71 vaccine protects children against HFMD
Influenza vaccination important for risk groups
Bharat‘s rotavirus vaccine is safe and modestly efficacious
Successfully avoiding the cold-chain for vaccines
FDA approval for Stallergenes’ sublingual grass pollen allergy immunotherapy
HPV vaccination campaign could change from three to two doses in the UK
Valneva continues phase 2/3 trial of Pseudomonas aeruginosa vaccine